Predictive value of negative 3T multiparametric magnetic resonance imaging of the prostate on 12‐core biopsy results
Open Access
- 22 January 2016
- journal article
- urology oncology
- Published by Wiley in BJU International
- Vol. 118 (4) , 515-520
Abstract
Objectives: To evaluate the cancer detection rates for men undergoing 12‐core systematic prostate biopsy with negative prebiopsy multiparametric magnetic resonance imaging (mp MRI ) results. Materials and Methods: Clinical data from consecutive men undergoing prostate biopsy who had undergone prebiopsy 3T mp MRI from December 2011 to August 2014 were reviewed from an institutional review board‐approved prospective database. Men with negative prebiospy mp MRI results (neg MRI ) before biopsy were identified for the present analysis. Clinical features, cancer detection rates and negative predictive values were summarized. Results: Seventy five men with neg MRI underwent systematic 12‐core biopsy during the study period. In the entire cohort, men with no previous biopsy, men with previously negative biopsy and men enrolled in active surveillance protocols, the overall cancer detection rates were 18.7, 13.8, 8.0 and 38.1%, respectively, and the detection rates for Gleason score ( GS ) ≥7 cancer were 1.3, 0, 4.0 and 0%, respectively. The NPV s for all cancers were 81.3, 86.2, 92.0, and 61.9, and for GS ≥7 cancer they were 98.7, 100, 96.0 and 100%, respectively. Conclusions: A negative prebiopsy mp MRI confers an overall NPV of 82% on 12‐core biopsy for all cancer and 98% for GS ≥7 cancer. Based on biopsy indication, these findings assist in prebiopsy risk stratification for detection of high‐risk disease and may provide guidance in the decision to pursue biopsy.Keywords
This publication has 31 references indexed in Scilit:
- Comparison of Interreader Reproducibility of the Prostate Imaging Reporting and Data System and Likert Scales for Evaluation of Multiparametric Prostate MRIAmerican Journal of Roentgenology, 2013
- Transperineal Magnetic Resonance Image Targeted Prostate Biopsy Versus Transperineal Template Prostate Biopsy in the Detection of Clinically Significant Prostate CancerJournal of Urology, 2013
- Targeted Biopsy in the Detection of Prostate Cancer Using an Office Based Magnetic Resonance Ultrasound Fusion DeviceJournal of Urology, 2013
- Negative predictive value for cancer in patients with “Gray‐Zone” PSA level and prior negative biopsy: Preliminary results with multiparametric 3.0 tesla MRJournal of Magnetic Resonance Imaging, 2012
- ESUR prostate MR guidelines 2012European Radiology, 2012
- Prospective Assessment of Prostate Cancer Aggressiveness Using 3-T Diffusion-Weighted Magnetic Resonance Imaging–Guided Biopsies Versus a Systematic 10-Core Transrectal Ultrasound Prostate Biopsy CohortEuropean Urology, 2012
- Magnetic Resonance Imaging/Ultrasound Fusion Guided Prostate Biopsy Improves Cancer Detection Following Transrectal Ultrasound Biopsy and Correlates With Multiparametric Magnetic Resonance ImagingJournal of Urology, 2011
- Role of magnetic resonance imaging before initial biopsy: comparison of magnetic resonance imaging‐targeted and systematic biopsy for significant prostate cancer detectionBJU International, 2011
- Is it time to consider a role for MRI before prostate biopsy?Nature Reviews Clinical Oncology, 2009
- Dynamic Contrast Enhanced, Pelvic Phased Array Magnetic Resonance Imaging of Localized Prostate Cancer for Predicting Tumor Volume: Correlation With Radical Prostatectomy FindingsJournal of Urology, 2006